Genentech

Genentech antibody spotlights new target for antibiotic-resistant bacteria
Genentech antibody spotlights new target for antibiotic-resistant bacteria
Fierce Biotech
Genentech
antibiotic resistance
antibiotics
R&D
drug discovery
BamA enzyme
Flag link:
After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive
After FDA setback, Bellicum bolsters R&D team with ex-Genentech executive
Fierce Biotech
FDA
Bellicum
R&D
Genentech
Flag link:
[forum discussion]Over 50
[forum discussion]Over 50
Cafepharma Message Boards
Genentech
Flag link:
Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven
Genentech beefs up its PD-L1 combo pipeline, signing the ‘don’t eat me’ specialists at Forty Seven
Endpoints
Genentech
anti-PD-1 immunotherapy
Forty Seven
Flag link:
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Roche Gains Ground on Rivals With Drug Combo’s Success in Lung Cancer
Xconomy
Roche
lung cancer
Genentech
Tecentriq
Flag link:
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning
Xconomy
Genentech
FDA
hemophilia A
Hemlibra
Flag link:
Genentech inks $650M deal with protein degradation pioneer Arvinas
Genentech inks $650M deal with protein degradation pioneer Arvinas
Endpoints
Genentech
targeted protein degradation
Arvinas
R&D
Flag link:
Last week in pharma.bio.device.lab November 5-11 2017
Last week in pharma.bio.device.lab November 5-11 2017
CP Wire
layoffs
Eli Lilly
Genentech
Amgen
Valeant Pharmaceuticals
Addyi
FDA
Scott Gottlieb
physician payments
Flag link:
Amgen and Genentech are the latest drug makers to lay off workers
Amgen and Genentech are the latest drug makers to lay off workers
Stat
Amgen
Genentech
layoffs
R&D
drug manufacturing
Merck
drug reps
Flag link:
[forum discussion]Huge Headcount Reductions
[forum discussion]Huge Headcount Reductions
Cafepharma Message Boards
layoffs
Genentech
Flag link:
[forum discussion]Should rank reports be eliminated?
[forum discussion]Should rank reports be eliminated?
Cafepharma Message Boards
drug reps
MS
multiple sclerosis
Genentech
Flag link:
New target could yield treatment for Alzheimer's, ALS and more
New target could yield treatment for Alzheimer's, ALS and more
Fierce Biotech
Genentech
Roche
drug development
R&D
Alzheimer's disease
ALS
Flag link:
Exelixis and Genentech hammer out new deal terms
Exelixis and Genentech hammer out new deal terms
BioPharma Dive
Exelixis
Genentech
Cotellic
melanoma
Flag link:
Roche looks into PML report for Ocrevus patient
Roche looks into PML report for Ocrevus patient
BioPharma Dive
Roche
PML
Ocrevus
Genentech
MS
multiple sclerosis
Flag link:
Roche unit Genentech takes on Pfizer with new lung cancer data
Roche unit Genentech takes on Pfizer with new lung cancer data
BioPharma Dive
Roche
Genentech
Pfizer
Xalkori
Alecensa
non-small cell lung cancer
Flag link:
Study evaluates drug-device combo therapy for deep vein thrombosis
Study evaluates drug-device combo therapy for deep vein thrombosis
Drug Delivery Business News
drug-device combos
devices
DVT
deep vein thrombosis
PCDT
Medtronic
Boston Scientific
BSN Medical
Genentech
Flag link:
The Demise of the BPCIA Patent Dance?
The Demise of the BPCIA Patent Dance?
FDA Law Blog
BPCIA
patents
Genentech
Amgen
Sandoz
Avastin
Flag link:
Amgen and the BPCIA Patent Dance – Redux
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Amgen
patents
BPCIA
FDA
Sandoz
Neupogen
generics
Genentech
Avastin
Flag link:
Can the new CEO at Genentech maintain a tradition of groundbreaking R&D?
Can the new CEO at Genentech maintain a tradition of groundbreaking R&D?
Endpoints
Genentech
Pharma CEOs
R&D
Bill Anderson
Ian Clark
Flag link:
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Yahoo
FDA
Genentech
Halozyme
rituximab
blood cancer
Flag link:

Pages